Kraig Biocraft Laboratories, Inc financial data

Symbol
KBLB on OTC
Industry
Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)
Location
2723 South State Street, Suite 150, Ann Arbor, MI
State of incorporation
WY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 20.4 % -51.1%
Quick Ratio 0.08 % 0%
Debt-to-equity -139 % +28.7%
Return On Equity 58.9 % -5.17%
Return On Assets -151 % -131%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.04B shares +0.48%
Entity Public Float 42.3M USD -15.4%
Weighted Average Number of Shares Outstanding, Basic 1.04B shares +0.48%
Weighted Average Number of Shares Outstanding, Diluted 1.04B shares +0.48%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 176K USD -12.7%
General and Administrative Expense 2.27M USD +167%
Operating Income (Loss) -3.55M USD -82.8%
Nonoperating Income (Expense) -325K USD +54.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.87M USD -46%
Net Income (Loss) Attributable to Parent -3.87M USD -46%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.19M USD -58.9%
Inventory, Net 6.88K USD +4.62%
Assets, Current 1.24M USD -58.7%
Property, Plant and Equipment, Net 46.5K USD -37.3%
Operating Lease, Right-of-Use Asset 98.7K USD -8.17%
Assets 2.03M USD -44.1%
Accrued Liabilities, Current 191K USD
Liabilities, Current 9.34M USD +8.99%
Operating Lease, Liability, Noncurrent 42.5K USD -22.3%
Liabilities 9.38M USD +8.79%
Accumulated Other Comprehensive Income (Loss), Net of Tax 13K USD
Retained Earnings (Accumulated Deficit) -52.2M USD -8.01%
Stockholders' Equity Attributable to Parent -7.36M USD -47.2%
Liabilities and Equity 2.03M USD -44.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -490K USD -23.8%
Net Cash Provided by (Used in) Financing Activities -15K USD 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -505K USD -22.9%
Deferred Tax Assets, Valuation Allowance 5.34M USD +9.32%
Operating Lease, Liability 100K USD -6.87%
Depreciation 27.7K USD +3.66%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.87M USD +23%
Lessee, Operating Lease, Liability, to be Paid 115K USD -2.56%
Operating Lease, Liability, Current 57.5K USD +9.13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 13.1K USD +52%
Lessee, Operating Lease, Liability, to be Paid, Year One 51.5K USD -1.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14.5K USD +43%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.92K USD +37.4%
Deferred Tax Assets, Operating Loss Carryforwards 5.34M USD +9.32%
Preferred Stock, Shares Issued 0 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 26.1K USD
Operating Lease, Payments 13.4K USD
Additional Paid in Capital 12.2M USD +11.6%
Preferred Stock, Shares Outstanding 0 shares